Episode
Rethinking Osteoarthritis: Targeting Inflammation in Dogs With Dr. Tarantino
- Published
- Jun 18, 2026
- Duration seconds
- 1541
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/clinician-s-brief-the-podcast-86369/episodes/rethinking-osteoarthritis-targeting-inflammation-in-dogs-with-dr-tarantino/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/clinician-s-brief-the-podcast-86369/rethinking-osteoarthritis-targeting-inflammation-in-dogs-with-dr-tarantino.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
As our understanding of canine osteoarthritis deepens and treatment options continue to expand, there's never been a better opportunity to refine how we approach this disease in practice. In this episode of the Partner Podcast, Dr. Beth invites Dr. Monica Tarantino to explore what's actually happening in the arthritic joint, why inflammation deserves its own place in the treatment conversation, and how she navigates anti-inflammatory options in her senior patients. Sponsored by Elanco Indication Galliprant controls pain and inflammation associated with osteoarthritis in dogs. Important Safety Information For use in dogs only. Keep this and all medications out of reach of children and pets to prevent accidental ingestion or overdose. Galliprant is a non-COX inhibiting NSAID. As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. Evaluation for pre-existing conditions and regular monitoring are recommended. Do not use in dogs that have a hypersensitivity to grapiprant. Concomitant use of Galliprant with other NSAIDs or corticosteroids should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. Owners should be advised to observe for signs of potential drug toxicity. Adverse reactions may include vomiting, diarrhea, decreased appetite, watery or bloody stools, and decreases in serum albumin and total protein. Visit http://elancolabels.com/us/galliprant for full prescribing information. Contact us: [email protected] Where to find us: Website: CliniciansBrief.com/Podcasts YouTube: Youtub…